Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

SCM Pharma

SCM Pharma is a contract development & manufacturing organisation (CDMO) that develops and makes novel, difficult and dangerous drugs on behalf of our clients. Our formulation development, cGMP manufacturing and aseptic processing services include the sterile filling of liquids, gels and powders (including flammable products) into a range of final dosage forms including ampoules, vials, cartridges, syringes and bottles. So if you’re a pharmaceutical, biotech, medical device or healthcare institution in need of formulation development, clinical manufacturing or contract filling involving a complex product or process – let’s talk.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

SCM Pharma
Unit 6 Regents Drive, Low Prudhoe Industrial Estate, Prudhoe, Northumberland, NE42 6PX, United Kingdom
+44(0) 1661 833 693
Contact SCM Pharma
Website

 Latest Content from PMHub 

Webinar: Observational Research

White Papers and Resources | March 27, 2015 | Inizio

Presenting a window on the world of your customer

Webinar: The Brazil Conundrum

White Papers and Resources | March 27, 2015 | Inizio

Conducting research in one of the world's largest pharma markets

Webinar: Demand calibration: What’s inside the black box?

White Papers and Resources | March 27, 2015 | Inizio

The process of demand calibration of preference share (down-weighting) is often a proprietary "black box" technique, which can mean that the client is unsure how the calibrated figure has been...

Free Thinking: Behavioural economics

White Papers and Resources | March 27, 2015 | Inizio

Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

Article: The Colombia Conundrum

White Papers and Resources | March 27, 2015 | Inizio

Published in eye for pharma 30 January by Marc Yates

Ageing in China: The Implications for Healthcare

White Papers and Resources | March 27, 2015 | Inizio

Published in eye for pharma 12 December by Marc Yates

5 years on from the Brazilian Generics Drugs Act, is there still an opportunity for branded originator drugs?

White Papers and Resources | March 27, 2015 | Inizio

Published in Eye for Pharma 10 November by Marc Yates

Webinar: The storytelling method that works for e-detailing

White Papers and Resources | March 26, 2015 | Anthill Agency

If you can involve healthcare professionals in a story, they will be more open to your arguments.

Understanding the ‘adoption ladder’ in closed loop marketing

White Papers and Resources | March 20, 2015 | Anthill Agency

Did you know that the very barriers to your product can be turned around to drive its success? Learn the judo strategy that is at the heart of great e-detailing.

Evolution of the wearable tech revolution

White Papers and Resources | March 17, 2015 | Blue Latitude Health

Stuart Goodman delves into the world of wearables, further analysing what role they play in pharma’s future.